TCI Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2
Closed -$72 2459
2023
Q1
$72 Hold
2
﹤0.01% 2425
2022
Q4
$73 Sell
2
-4
-67% -$158 ﹤0.01% 2416
2022
Q3
$0 Buy
+6
New +$388 ﹤0.01% 2679
2022
Q1
Sell
-77
Closed -$8K 2538
2021
Q4
$8K Hold
77
﹤0.01% 1385
2021
Q3
$7K Hold
77
﹤0.01% 1404
2021
Q2
$7K Hold
77
﹤0.01% 1257
2021
Q1
$6K Sell
77
-3
-4% -$226 ﹤0.01% 1192
2020
Q4
$5K Buy
+80
New +$4.99K ﹤0.01% 921
2019
Q4
Sell
-10
Closed -$1K 1716
2019
Q3
$1K Buy
+10
New +$513 ﹤0.01% 1430
2019
Q1
Sell
-9
Closed 1584
2018
Q4
$0 Buy
9
+1
+13% +$46 ﹤0.01% 1713
2018
Q3
$0 Buy
+8
New +$392 ﹤0.01% 1625

Other funds holding SYNH

TCI Wealth Advisors's SYNH Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 2 shares — an estimated $72 sold.

TCI Wealth Advisors first reported a position in SYNH in Q3 2018 and held it in 11 quarters. The position peaked at $8K in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 2 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $72.
  • TCI Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 11 quarters.
  • TCI Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $8K in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.